Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.

Literature DB >> 16187055

Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.

P Castro¹, A Soriano, C Escrich, G Villalba, M Sarasa, J Mensa.

Abstract

Ventriculoperitoneal shunt infection is a serious clinical problem for which implant removal is considered the treatment of choice. However, surgery is sometimes associated with considerable risks that may outweigh the benefits. Presented here is a case of ventriculoperitoneal shunt infection treated successfully with linezolid without implant removal. This case shows linezolid could be a therapeutic alternative when surgery is contraindicated.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 16187055 DOI： 10.1007/s10096-005-0015-9

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

21 in total

1. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.

Authors: R Hachem; C Afif; Z Gokaslan; I Raad
Journal: Eur J Clin Microbiol Infect Dis Date: 2001-06 Impact factor: 3.267

2. Bacterial adhesion to cerebrospinal fluid shunts.

Authors: J A Guevara; G Zúccaro; A Trevisán; C D Denoya
Journal: J Neurosurg Date: 1987-09 Impact factor: 5.115

3. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.

Authors: I Morissette; M Gourdeau; J Francoeur
Journal: Can J Neurol Sci Date: 1993-05 Impact factor: 2.104

4. The management of cerebrospinal fluid shunt infections: a clinical experience.

Authors: H E James; J W Walsh; H D Wilson; J D Connor
Journal: Acta Neurochir (Wien) Date: 1981 Impact factor: 2.216

5. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience.

Authors: R George; L Leibrock; M Epstein
Journal: J Neurosurg Date: 1979-12 Impact factor: 5.115

6. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).

Authors: M Bassetti; A Di Biagio; G Cenderello; V Del Bono; A Palermo; M Cruciani; D Bassetti
Journal: J Infect Date: 2001-08 Impact factor: 6.072

7. Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.

Authors: I K Pople; R Bayston; R D Hayward
Journal: J Neurosurg Date: 1992-07 Impact factor: 5.115

8. Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid.

Authors: C J Gill; M A Murphy; D H Hamer
Journal: J Infect Date: 2002-08 Impact factor: 6.072

9. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.

Authors: Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton
Journal: Clin Infect Dis Date: 2003-03-18 Impact factor: 9.079

10. Sensorineural hearing loss associated with intrathecal vancomycin.

Authors: Olga M Klibanov; Joanne E Filicko; Joseph A DeSimone; David S Tice
Journal: Ann Pharmacother Date: 2003-01 Impact factor: 3.154

4 in total

1. Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment.

Authors: A-J Kruse; S M Peerdeman; P M Bet; Y J Debets-Ossenkopp
Journal: Eur J Clin Microbiol Infect Dis Date: 2006-02 Impact factor: 3.267